PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $108,000 | -16.3% | 45,400 | 0.0% | 0.00% | – |
| Q2 2022 | $129,000 | -7.2% | 45,400 | -5.9% | 0.00% | – |
| Q1 2022 | $139,000 | +215.9% | 48,268 | +235.9% | 0.00% | – |
| Q4 2021 | $44,000 | -57.3% | 14,368 | -2.0% | 0.00% | – |
| Q3 2021 | $103,000 | -23.7% | 14,668 | 0.0% | 0.00% | – |
| Q2 2021 | $135,000 | -0.7% | 14,668 | +4.6% | 0.00% | – |
| Q1 2021 | $136,000 | -5.6% | 14,025 | -0.1% | 0.00% | – |
| Q4 2020 | $144,000 | -98.5% | 14,041 | -98.4% | 0.00% | -100.0% |
| Q2 2020 | $9,443,000 | +8.0% | 905,357 | -12.6% | 0.00% | 0.0% |
| Q1 2020 | $8,741,000 | +45.6% | 1,035,611 | +50.9% | 0.00% | 0.0% |
| Q4 2019 | $6,005,000 | -3.8% | 686,306 | +18.3% | 0.00% | 0.0% |
| Q3 2019 | $6,243,000 | -1.5% | 579,971 | +16.3% | 0.00% | 0.0% |
| Q2 2019 | $6,337,000 | -79.2% | 498,609 | -36.6% | 0.00% | -75.0% |
| Q1 2019 | $30,488,000 | +11998.4% | 785,965 | +18341.2% | 0.00% | – |
| Q2 2018 | $252,000 | -11.3% | 4,262 | +2.0% | 0.00% | – |
| Q1 2018 | $284,000 | -99.9% | 4,179 | -99.8% | 0.00% | -100.0% |
| Q4 2017 | $195,379,000 | -69.0% | 1,976,517 | -62.4% | 0.03% | -70.4% |
| Q3 2017 | $629,474,000 | +109.8% | 5,256,567 | +53.1% | 0.11% | +100.0% |
| Q2 2017 | $300,103,000 | +602.1% | 3,433,672 | +198.9% | 0.05% | +575.0% |
| Q1 2017 | $42,741,000 | +105.2% | 1,148,945 | +69.4% | 0.01% | +100.0% |
| Q4 2016 | $20,828,000 | -66.7% | 678,435 | -27.2% | 0.00% | -69.2% |
| Q3 2016 | $62,455,000 | +106.2% | 931,474 | -8.4% | 0.01% | +116.7% |
| Q2 2016 | $30,293,000 | -39.5% | 1,016,874 | -40.4% | 0.01% | -45.5% |
| Q1 2016 | $50,112,000 | -62.8% | 1,706,222 | -0.8% | 0.01% | -60.7% |
| Q4 2015 | $134,818,000 | +3.4% | 1,719,612 | -0.6% | 0.03% | -3.4% |
| Q3 2015 | $130,426,000 | -46.7% | 1,730,703 | -17.4% | 0.03% | -42.0% |
| Q2 2015 | $244,527,000 | -65.5% | 2,094,447 | -30.1% | 0.05% | -65.8% |
| Q1 2015 | $707,879,000 | +35.2% | 2,998,090 | +8.4% | 0.15% | +31.5% |
| Q4 2014 | $523,653,000 | -38.0% | 2,766,701 | -21.8% | 0.11% | -39.7% |
| Q3 2014 | $844,400,000 | +298.5% | 3,539,423 | +10.2% | 0.18% | +300.0% |
| Q2 2014 | $211,884,000 | -31.2% | 3,210,367 | +8.6% | 0.05% | -33.3% |
| Q1 2014 | $307,760,000 | -49.6% | 2,955,248 | -49.9% | 0.07% | -1.4% |
| Q4 2013 | $610,108,000 | +738.7% | 5,893,048 | +334.7% | 0.07% | +288.9% |
| Q3 2013 | $72,742,000 | -40.5% | 1,355,606 | -50.8% | 0.02% | +12.5% |
| Q2 2013 | $122,334,000 | – | 2,757,134 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |